PT  - JOURNAL ARTICLE
AU  - ARTEMIS G. KOROVESI
AU  - ATHANASIOS K. ANAGNOSTOPOULOS
AU  - VASILEIOS PIERROS
AU  - DIMITRIOS J. STRAVOPODIS
AU  - GEORGE TH. TSANGARIS
TI  - Normal Mouse Brain Proteome II: Analysis of Brain Regions by High-resolution Mass Spectrometry
AID  - 10.21873/cgp.20230
DP  - 2020 Nov 01
TA  - Cancer Genomics - Proteomics
PG  - 757--767
VI  - 17
IP  - 6
4099  - http://cgp.iiarjournals.org/content/17/6/757.short
4100  - http://cgp.iiarjournals.org/content/17/6/757.full
SO  - Cancer Genomics Proteomics2020 Nov 01; 17
AB  - Background/Aim: Proteomics technologies provide fundamental insights into the high organizational complexity and diversity of the central nervous system. In the present study, high-resolution mass spectrometry (MS) was applied in order to identify whole-proteome content of anatomically distinct and functionally specific mouse brain regions. Materials and Methods: Brains from eight 8-week-old C57BL/6N normal male mice were separated into seven anatomically district regions. The protein content of each region was analyzed by high-throughput nano-liquid chromatography-MS/MS Orbitrap elite technology. Results: A total of 16,574 proteins were identified: 2,795 in cerebral cortex, 2,311 in olfactory bulb, 2,246 in hippocampus, 2,247 in hypothalamus, 2,250 in mid brain, 2,334 in cerebellum and 2,391 in medulla. Of these proteins, 534 were uniquely expressed in cerebral cortex, 323 in olfactory bulb, 230 in hippocampus, 272 in hypothalamus, 1,326 in mid brain, 320 in cerebellum and 268 in medulla. Conclusion: These data represent the most comprehensive proteomic map of the normal mouse brain and they might further be used in studies related to brain diseases, including cancer and neurodegenerative diseases.